請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64390完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 黃鵬林(Pung-Ling Huang) | |
| dc.contributor.author | Ling Lin | en |
| dc.contributor.author | 林靈 | zh_TW |
| dc.date.accessioned | 2021-06-16T17:44:27Z | - |
| dc.date.available | 2017-08-27 | |
| dc.date.copyright | 2012-08-27 | |
| dc.date.issued | 2012 | |
| dc.date.submitted | 2012-08-14 | |
| dc.identifier.citation | 陳建豪. 2006. 家禽流行性感冒病毒血球凝集素蛋白之表現及其應用. 台灣大學獸醫學研究所碩士論文.
吳靜霞. 2006. 應用轉殖胡蘿蔔表達禽流感病毒疫苗基因之研究. 國立臺灣大學園藝學研究所碩士論文. 杜韋萱. 2010. 應用轉殖胡蘿蔔表達禽流感病毒疫苗基因之研究. 國立臺灣大學園藝學研究所碩士論文. Anonymous. 1991. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). Morbidity Mortality Weekly Rep 40: 1-25. Arlen, P. A., R. Falconer, S. Cherukumilli, A. Cole, A. M. Cole, K. K. Oishi, and H. Daniell. 2007. Field production and functional evaluation of chloroplast-derived interferon-alpha2b. Plant Biotechnol. J. 5: 511-525. Arntzen, C. J., Mason, H. S. 1997. Oral vaccine production in the edible tissues of transgenic plants, in: Levine, M. M., Woodrow, G. C., Kaper, J. B., Cobon, G. S. (Eds.), in New Generation Vaccines, Second Edition, Marcel Dekker, New York, pp. 263-277. Barquet, N., D. P. Smallpox. 1997. The triumph over the most terrible of the ministers of death. Ann Intern Med.127: 635-642. Binns. A. N., and M. F. Thomashaw. 1988. Cell biology of Agrobacterium infection and transformation of plants. Annu. Rev. Microbiol. 42: 575-606. Capua, I., and D. J. Alexander. 2004. Human health implications of avian influenza viruses and paramyxoviruses. Eur. J. Clin. Microbiol. Infect. Dis. 23: 1-6. Capua, I., C. Terregino, G. Cattoli, F. Mutinelli, and J. F. Rodriguez. 2003. Development of a DIVA-Differentiating infected from vaccinated animals strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathology 32: 47-55. Chen, W., P. A. Calvo, D. Malide, J. Gibbs, U. Schubert, I. Bacik, S. Basta, R. O’Neill, J. Schickli, P. Palese, P. Henklein, J. R. Bennink, and J. W. Yewdell. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7: 1306-1312. Chen, H., K. Subbarao, D. Swayne, Q. Chen, X. Lu, J. Katz, N. Cox, Y. Matsuoka. 2003. Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate. Vaccine 21: 1974-1979. Chen, M., X.W. Liu, Z.K. Wang, J. Song, Q.S. Qi, and P.G. Wang. 2005. Modification of plant N-glycans processing: the future of producing therapeutic protein by transgenic plants. Med. Res. Rev. 25: 343-60. Citovsky, V., J. Zupan, D. Warnick, P. C. Zambryski. 1992. Nuclear localization of Agrobacterium VirE2 protein in plant cells. Science 256: 1802-1805. Claas, E. C., A. D. Osterhaus, R. V. Beek, J. C. Jong, G. F. Rimmelzwaan, D. A. Senne, S. Krauss, K. F. Shortridge, and R. G. Webster. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351: 472-477. Cramer, C., J.G. Boothe, and K.K. Oishi. 1999. Transgenic plants for therapeutic proteins: linking upstream and downstream strategies. Curr. Topics Microbiol. Immunol. 240: 95-118. Crosby, A. 1976. Epidemic and peace, 1918. 1976. Greenwood Press, Westport, CT. pp. 145-170. Daniell, H., M. S. Khan, and L. Allison. 2002. Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology. Plant Science 7: 84-91. Daniell, H., S. B. Lee, T. Panchal, and P. O. Wiebe. 2001. Expression of native cholera toxin B sub-unit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol. 311:1001-1009. Daniell, H., S. Chebolu, S. Kumar, M. Singleton, and R. Falconer. 2005. Chloroplast-derived vaccine antigens and other therapeutic proteins. Vaccine 23: 1779-1783. De Cosa, B., W. Moar, S. B. Lee, M. Miller, and H. Daniell. 2001. Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat. Biotechnol. 19: 71-74. De Gray, G., K. Rajasekaran, F. Smith, J. Sanford, and H. Daniell. 2001. Expression of an antimicrobial peptide via the chloroplast genome to control phytopathogenic bacteria and fungi. Plant Physiol. 127: 852-862. Fischer, R., and N. Emans. 2000. Molecular farming of pharmaceutical proteins. Transgenic Res. 9: 279-299. Fouchier, R. A., P. M. Schneeberger, F. W. Rozendaal, J. M. Broekman, S. A. Kemink, V. Munster, T. Kuiken, G. F. Rimmelzwaan, M. Schutten, G. J. Van Doornum, G. Koch, A. Bosman, M. Koopmans, and A. D. Osterhaus. 2004. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. USA 101: 1356-1361. Fouchier, R. A., V. Munster, A. Wallensten, T. M. Bestebroer, S. Herfst, D. Smith, G. F. Rimmelzwaan, B. Olsen, and A. D. Osterhaus. 2005. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79: 2814-2822. Ganz, P.R. 1996. Expression of human blood proteins in transgenic plants: the cytokine GM-CSF as a model protein. In Transgenic plants: a production system for industrial and pharmaceutical proteins. pp. 281-297. Ghendon, Y. Z., S. G. Markushin, I. I. Akopova, I. B. Koptiaeva, E. A. Nechaeva, L. A. Mazurkova, I. F. Radaeva, and T. D. Kolokoltseva. 2005. Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine. Vaccine 23: 4678-4684. Giddings, G., G. Allison, D. Brooks, and A. Carter. 2000. Transgenic plants as factories for biopharmaceuticals. Nature 18: 1151-1155. Halvorson, D. A. 2002. The control of H5 or H7 mildly pathogenic avian influenza: a role for inactivated vaccine. Avian Pathology 31: 5-12. Halvorson, D. A., D. D. Frame, A. J. Friendshuh, and D. P. Shaw. 1998. Outbreaks of low pathogenicity avian influenza in USA. In Proceedings of the 4th International Symposium on Avian Influenza. Athens, GA, USA. pp. 36-46. Haq, T. A., Mason, H. S., Clements, J. D., Arntzen, C. J. 1995. Oral immunisation with a recombinant bacterial antigen produced in transgenic plants. Science 268: 714-716. Horimoto, T., T. Ito, D. J. Alexander, and Y. Kawaoka. 1995. Cleavability of hemagglutinin from an extremely virulent strain of avian influenza virus containing a unique cleavage site sequence. J. Vet. Med. Sci. 57: 927-930. Horn, M.E., S.L. Woodard, and J.A. Howard. 2004. Plant molecular farming: Systems and products. Plant Cell Rep. 22: 711-720. Kilbourne, E. D. Influenza. 1987. Plenum medical book company. New York and London. Kong, Q., L, Richter., Y. F. Yang., C. J. Arntzen., H. S. Mason, and Y. Thanavala. 2001. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc. Natl. Acad. Sci. USA 98: 11539-11544. Koopmans, M., B. Wilbrink, M. Conyn, G. Natrop, H. van der Nat, H. Vennema, A. Meijer, J. van Steenbergen, R. Fouchier, A. Osterhaus, and A. Bosman. 2004. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in The Netherlands. Lancet 363: 587-593. Korban, S. S., Sergei F. K., and Dennis E. B. 2002. Foods as Production and Delivery Vehicles for Human Vaccines. J. Am. Coll. Nutr. 21: 212-217. Ladisch, M. R. 2001. Bioseparations Engineering. Principles, Practice and Economics. John Wiley & Sons, NY, USA. Lamb, R. A., and R. M. Krug. 2001. Orthomyxoviridae: The viruses and their replication. In: Fields Virology, 4th ed. (D. M. Knipe and P. M. Howley, eds.). Philadelphia: Lippincott, Williams and Wilkins, pp. 1487-1532. Leelavathi, S., and V. S. Reddy. 2003. Chloroplast expression of His-tagged GUS-fusions: A general strategy to overproduce and purify foreign proteins using transplastomic plants as bioreactors. Mol. Breeding 11: 49-58. Li, S., C. Liu, A. Klimov, K. Subbarao, M. L. Perdue, D. Mo, Y. Ji, L. Woods, S. Hietala, and M. Bryant. 1999. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J. Infect. Dis. 179: 1132-1138. Lilly, J. W., M. J. Havey, S. A. Jackson, and J. M. Jiang. 2001. Cytogenomic analyses reveal the structural plasticity of the chloroplast genome in higher plants. Plant Cell 13: 245-254. Lin, J., J. Zhang, X. Dong, H. Fang, J. Chen, N. Su, Q. Gao, Z. Zhang, Y. Liu, Z. Wang, M. Yang, R. Sun, C. Li, S. Lin, M. Ji, Y. Liu, X. Wang, J. Wood, Z. Feng, Y. Wang, W. Yin. 2006. Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet 368: 991-997. Lu, X., T. M. Tumpey, T. Morken, S. R. Zaki, N. J. Cox, and J. M. Katz. 1999. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73: 5903-5911 . Ma, J.K., and A. Hiatt. 1996. Expressing antibodies in plants for immunotherapy. In Transgenic plants: a production system for industrial and pharmaceutical proteins. pp. 229-243. Maliga, P. 2003. Progress towards commercialization of plastid transformation technology. Trends Biotechnol. 21: 20-28. Maliga, P. 2004. Plastid transformation in higher plants. Annu. Rev. Plant Biol. 55: 289-313. Mason, H.S., Lam, D. M. K., Arntzen, C. J. 1992. Expression of hepatitis B surface antigen in transgenic plants. Proc. Natl. Acad. Sci. USA 89: 11745-11749. Miele, L. 1997. Plants as bioreactors for biopharmaceuticals: regulatory considerations. Trends Biotechnol. 15: 45-50. Millan, A. F. S., A. Mingeo-Castel, M. Miller, and H. Daniell. 2003. A chloroplast transgenic approach to hyper-express and purify human serum albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol. J. 1: 71-79. Molina A, S. Hervas-Stubbs, H. Daniell, A. M. Mingo-Castel, and Jon Veramendi . 2004. High yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol. 2:141-153. Olofsson, S., U. Kumlin, K. Dimock, and N. Arnberg. 2005. Avian influenza and sialic acid receptors: more than meets the eye. Lancet Infect. Dis. 5: 184-188. Oxford, J. S., C. Manuguerra, O. Kistner, A. Linde, M. Kunze, W. Lange, B. Schweiger, G. Spala, H. Rebelo de Andrade, P. R. P’erez Bre˜na, J. Beytout, L. Brydak, D. Caraffa de Stefano, O. Hungnes, J. Kyncl, E. Montomoli, A. Gil de Miguel, R. Vranckx, and A. Osterhaus. 2005. A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines. Vaccine 23: 5440-5449. Palker, T., I. Kiseleva, K. Johnston, Q. Sua, T. Toner, C. Szymkowiak, W. Kwan, B. Rubin, L. Petrukhin, J. Wlochowski, J. Monteiro, N. Kraiouchkine, D. DiStefano, L. Rudenko, A. Shawa, R. Youil. 2004. Protective efficacy of intranasal coldadapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants. Virus Res. 105: 183-194. Parmenter, D.L., J.G. Boothe, G.J.H. van Rooijen, E.C. Yeung, and M.M. Moloney. 1995. Production of biologically active hirudin in plant seeds using oleosin partitioning. Plant Mol. Biol. 29:1167-1180. Pen, J. 1996. Comparison of host systems for the production of recombinant proteins in: Owen M. R. L., Pen J. (Eds.), Transgenic plants: a production system for industrial and pharmaceutical proteins. John Wiley and Sons Ltd. pp. 149-167. Pe’rez-Herna’ndez, J. B., R. Swennen, and L. Sa’gi. 2006. Number and accuracy of T-DNA insertions in transgenic banana (Musa spp.) plants characterized by an improved anchored PCR technique. Transgenic Res. 15: 139-150. Perroncito, E. 1878. Epizoozia tifoide neigalliancei. Ann. Acad. Agric. Torino. 21:87-126. Richter, L.J., Y. Thanavala, C.J. Arntzen, and H.S. Mason. 2000. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 18:1167-1171. Ruiz, O. N., T. Quesada-Vargas, and H. Daniell, 2005. Characterization of heterologous operons in transgenic chloroplasts: Transcription processing, translation. Plant Physiol. 138: 1746-1762. Scholtissek, C. 1995. Molecular evolution of influenza viruses. Virus Genes 11: 209-215. Sergei, N. S., R. K. Salyaev., S. G. Pozdnyakov., N. I. Rekoslavskaya., A. E. Nesterov., T. S. Ryzhova., V. M. Sumtsova., N. V. Pakova., U. O. Mishutina., T. V. Kopytina, and R. W. Hammond. 2006. Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses. Biotechnol. Lett. 28:959-967. Smith, M.D., and B.R. Glick. 2000. The production of antibodies in plants. Biotechnol. Adv. 18: 85-89. Staub, J.M., B. Garcia, J. Graves, P. T. J. Hajdukiewicz, P. Hunter, N. Nehra, V. Paradkar, M. Schlittler, J. A. Carroll, L. Spatola, D. Ward, G. Ye, and D. A. Russell. 2000. High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat. Biotechnol. 18: 333-338. Stieneke-Grober, A., V. Martin, A. Herbert, S. Elliott, T. Gary, R. Christopher, K. Hans-Dieter, and G. Wolfgang. 1992. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO. J. 11: 2407-2414. Streatfield, S. J., J. M. Jilka , E. E. Hood, D. D. Turner, M. R. Bailey, J. M. Mayor, S. L. Woodard, K. K. Beifuss, M. E. Horn, D. E. Delaney, I. R. Tizard, and J. A. Howard. 2001. Plant-based vaccines: unique advantages. Vaccine 19: 2742-2748. Subbarao, K., A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, J. Huang, M. Hemphill, T. Rowe, M. Shaw, X. Xu, K. Fukuda, and N. Cox. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. 1998. Science 279: 393-396. Subbarao, K., H. Chen, D. Swayne, L. Mingay, E. Fodor, G. Brownlee, X. Xu, X. Lu, J. Katz, N. Cox, and Y. Matsuoka. 2003. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305: 192-200. Subbarao, K., and T. Joseph. 2007. Scientific barriers to developing vaccines against avian influenza viruses. Nature 7: 267-278. Svab, Z., P. Hajdukiewicz, and P. Maliga. 1990. Stable transformation of plastids in higher plants. Proc. Natl. Acad. Sci. USA 87: 8526-8530. Svab, Z., and P. Maliga. 1993. High-frequency plastid transformation in tobacco by selection for a chimeric aadA gene. Proc. Natl. Acad. Sci. USA 90: 913-917. Szmuness, W., C. E. Stevens., E. J. Harley., E. A. Zang., W. R. Oleszko., D. C. William., R. Sadovsky., J. M. Morrison, and A. Kellner. 1980. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N. Engl. J. Med. 303: 833-841. Tacket, C. O., Mason, H. S., Losonsky, G., Clements, J. D., Levine, M. M., Arntzen C. J. 1998. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nature Med. 4: 607-609. Thanavala, Y., M. Mahoney, S. Pal, A. Scott, L. Richter, N. Natarajan, P. Goodwin, C. J. Arntzen, and H. S. Mason. 2005. Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl. Acad. Sci. USA 102: 3378-3382. Thanavala, Y., Y. Yang, P. Lyons, H. S. Mason, and C. Arntzen. 1995. Immunogenicity of Transgenic Plant-derived Hepatitis B Surface Antigen. Proc. Nat. Acad. Sci. USA 92: 3358-3361. Tzfira, T., Y. Rhee, M. H. Chen, T. Kunik, V. Citovsky. 2000. Nucleic acid transport in plant-microbe interactions: the molecules that walk through the walls. Annu. Rev. Microbiol. 54: 187-219. Ruhlman, T., R. Ahangari, A. Devine, M. Samsam, and H. Daniell. 2007. Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts - oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol. J. 5: 495-510. Verma, D., and H. Daniell. 2007. Chloroplast vector system for biotechnology applications. Plant Physiology 145: 1129-1143. Verma, D., N. P. Samson, V. Koya, and H. Daniell. 2008. A protocol for expression of foreign genes in chloroplasts. Nature Protocols 3: 739-758. Villareal-Chavez, C., and E. R. Cruz. 2003. An update on avian influenza in Mexico. In: Proceedings of the 5th International Symposium on Avian Influenza. Georgia Center for Continuing Education, The University of Georgia, Athens, Georgia, USA Avian Diseases 47: 1002-1005. Wamplar, D., E. Lehman., J. Boger., W. McAleer, and E. Scolnick. 1985. Multiple chemical forms of the hepatitis B surface antigen produced in yeast. Proc. Natl. Acad. Sci. USA 82: 6830-6834. Wang, Y., H. Deng, X. Zhang, H. Xiao, Y. Jiang, Y. Song, L. Fang, S. Xiao, Y. Zhen, and H. Chen. 2009. Generation and immunogenicity of Japanese encephalitis virus envelope protein expressed in transgenic rice. Biochem. Biophys. Res. Commun. 380: 292-297. Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers, and Y. Kawaoka. 1992. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56: 152-179. Wood, G. W., J. W. McCauley, J. B. Bashiruddin, and D. J. Alexander. 1993. Deduced amino acid sequences at the haemagglutinin cleavage site of avian influenza A viruses of H5 and H7 subtypes. Arch. Virol. 130: 209-217. Wright, P., G. Neumann, and Y. Kawaoka. Orthomyxoviruses. 2007. In: Knipe D. M., editor. Fields Virology. 5th ed. USA: Lippincott, Williams and Wilkins, pp. 1691-1740. Yusibov, V., S.J. Streatfield, and N. Kushnir. 2011. Clinical development of plant-produced recombinant pharmaceuticals vaccines, antibodies and beyond. Human Vaccines 7: 1-9. Zhang, H., M. Liu, Y. Li , Y. Zhao , H. He, G. Yang, and C. Zheng. 2010. Oral immunogenicity and protective efficacy in mice of a carrot-derived vaccine candidate expressing UreB subunit against Helicobacter pylori. Protein Expr. Purif. 69: 127-131. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64390 | - |
| dc.description.abstract | 家禽流行性感冒 (Avian influenza) 簡稱禽流感，是一種發生於禽鳥間的流行性感冒，家禽中尤以雞、鴨最易受到感染，嚴重時常導致死亡，病毒傳染速度快，常造成農業上的重大損失。疫苗的研發為預防禽流感的方法之一，利用基因轉殖植物生產疫苗，不但可作為生物反應器進行大量生產而降低疫苗成本，亦可免去人類病原汙染的疑慮。
本研究先前已利用農桿菌媒介法轉殖編碼為醣蛋白之禽流感病毒表面抗原決定位 ha 基因至胡蘿蔔中，經聚合酶連鎖反應 (polymerase chain reaction) 和南方氏雜交分析可偵測到 ha 基因片段，利用酵素連結免疫吸附分析 (enzyme-linked immunosorbent assay) 可偵測到 65 kDa 之 HA 外源蛋白表達。為了提高 HA 外源蛋白表達量，進一步利用葉綠體轉殖法 (chloroplast transformation) 進行轉殖，期望提高胡蘿蔔轉殖株中 HA 外源蛋白表達量。 本研究以胡蘿蔔葉綠體中 rpoA 與 petD 基因作為側翼序列，將禽流感病毒表面抗原決定位 ha 基因構築於側翼序列之間，以基因槍法 (particle bombardment) 將構築質體轉殖至胡蘿蔔葉綠體中，以抗生素 spectinomycin 進行篩選，將具抗性之轉殖細胞進一步分析，經聚合酶連鎖反應可分析到 ha 基因片段，為確認目標基因確實轉殖至胡蘿蔔葉綠體中，利用側翼序列外之引子進行分析，亦可得到目標片段，顯示目標基因已轉殖至胡蘿蔔葉綠體中。萃取 RNA 進行反轉錄聚合酶連鎖反應 (reverse transcription polymerase chain reaction, RT-PCR) 可偵測到 ha 基因表現；進一步萃取轉殖株葉片之蛋白質，利用 HA 單株抗體進行免疫轉漬分析 (immunoblot analysis)，結果顯示轉殖株中皆含有 65 kDa 之 HA 蛋白，顯示外源基因可順利表達蛋白。 | zh_TW |
| dc.description.abstract | Avian influenza is an influenza in poultry flocks. Chickens and ducks are susceptible to infect (avian influenza virus, AIV) and often leading to death. The transmitted speed of the virus is very fast. AIV causes a great damages of the agriculture. Vaccine development is a strategy to prevent AIV. Transgenic plants have been used as a large-scale and low-cost production system of safe and pharmaceutical proteins.
Previously ha gene has been transfered into carrots by Agrobacterium tumefaciens-mediated transformation method. The ha gene encoding the AIV surface glycoprotein (hemagglutinin, HA), a major antigen of AIV agent. The foreign ha gene was detected by polymerase chain reaction and Southern blot analysis. Enzyme-linked immunoassays revealed that HA protein expression in transgenic carrot. In order to enhance the foreign protein expression, the ha gene was further transfered into carrot chloroplasts. The rpoA and petD genes derived from carrot chloroplast genome were used as flanking sequence for plasmid construction. The ha gene encoding the AIV surface glycoprotein was constructed between the flanking sequences and transfered into chloroplasts of carrot by particle bombardment. After antibiotic selection transgenic carrot calli were regenerated into plantlets. DNA from putative transgenic plants was extracted and the integration of ha gene in carrot chloroplast genome was confirmed by polymerase chain reaction (PCR). The results of reverse transcriptase polymerase chain reaction (RT-PCR) revealed that foreign gene was expressed in transgenic plants. Western blot analysis using HA monoclonal antibody showed that HA protein of 65 kDa was accumulated in all of the transgenic plants. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-16T17:44:27Z (GMT). No. of bitstreams: 1 ntu-101-R99628131-1.pdf: 1740564 bytes, checksum: 78ebc6802b4764bc91b49bef536277b3 (MD5) Previous issue date: 2012 | en |
| dc.description.tableofcontents | 摘要 i
Abstract ii 內容目次 I 圖表目次 II 壹、 前言 1 貳、 前人研究 2 一、 家禽流行性感冒 2 二、 基因轉殖植物生產醫藥用蛋白 5 (一)抗體 7 (二)疫苗 7 (三)其他醫藥用蛋白質 9 三、 葉綠體基因轉殖 9 參、 材料與方法 13 一、 試驗材料 13 (一) 核轉殖 13 (二) 葉綠體轉殖 13 二、 試驗方法 15 (一) 核轉殖株邊界序列分析 15 (二) 胡蘿蔔葉綠體基因轉殖與再生 18 (三) 葉綠體基因轉殖之擬轉殖株分析 19 肆、 結果 25 一、 葉綠體轉殖株的篩選及再生 25 二、 葉綠體轉殖株分析 25 (一) 胡蘿蔔轉殖株之分子驗證 25 (二) 胡蘿蔔轉殖株之基因表現分析 26 (三) 胡蘿蔔轉殖株之蛋白表現及定量分析 26 三、 核轉殖株之邊界序列分析 27 伍、 討論 43 一、 葉綠體轉殖於蛋白表達量之影響因子 43 二、 葉綠體轉殖技術生產疫苗之可行性 44 三、 胡蘿蔔核轉殖之邊界序列分析 45 陸、 結語 47 柒、 引用文獻 48 圖 1.葉綠體轉殖質體 pSHARF 之構築圖 24 圖 2.胡蘿蔔轉殖、篩選及再生過程 28 圖 3.胡蘿蔔癒傷組織轉殖葉綠體表現載體 pSHARF之DsRed表現情形 29 圖 4.胡蘿蔔 pSHARF擬轉殖株目標基因之聚合酶連鎖反應分析 30 圖 5.轉殖株葉片逆分化成癒傷組織及再生成小苗過程 31 圖 6.胡蘿蔔 pSHARF轉殖癒傷組織目標基因之聚合酶連鎖反應分析 32 圖 7.胡蘿蔔 pSHARF轉殖癒傷組織聚合酶連鎖反應分析 33 圖 8.胡蘿蔔 pSHARF轉殖癒傷組織側翼序列之聚合酶連鎖反應分析 34 圖 9.胡蘿蔔 pSHARF癒傷組織轉殖系插入序列之定序分析 35 圖 10.胡蘿蔔 pSHARF轉殖株之反轉錄聚合酶連鎖反應分析 36 圖 11.胡蘿蔔 pSHARF轉殖癒傷組織之反轉錄聚合酶連鎖反應分析 37 圖 12.免疫轉漬分析轉殖 pSHARF胡蘿蔔葉中HA蛋白的表現 38 圖 13.免疫轉漬分析轉殖pSHARF胡蘿蔔癒傷組織中HA蛋白的表現 39 圖 14.轉殖 pSHARF 胡蘿蔔葉中HA蛋白含量 40 圖 15.轉殖 pSHARF 胡蘿蔔癒傷組織中HA蛋白含量 41 圖 16.以APCR定出胡蘿蔔抗禽流感轉殖株H6之左邊界序列 42 表 1、T-DNA 邊界序列分析使用之引子與連結子序列 23 | |
| dc.language.iso | zh-TW | |
| dc.title | 應用轉殖胡蘿蔔表達禽流感病毒血球凝集素基因之研究 | zh_TW |
| dc.title | Studies on Expression of Avian Influenza Virus Hemagglutinin Gene in Transgenic Carrot | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 100-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.coadvisor | 杜宜殷(Yi-Yin Do) | |
| dc.contributor.oralexamcommittee | 何錦玟(Chin-Wen Ho),王金和(Ching-Ho Wang) | |
| dc.subject.keyword | 家禽流行性感冒,葉綠體基因轉殖,疫苗,血球凝集素,胡蘿蔔, | zh_TW |
| dc.subject.keyword | avian influenza,chloroplast transformation,vaccine,hemagglutinin,carrot, | en |
| dc.relation.page | 58 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2012-08-14 | |
| dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
| dc.contributor.author-dept | 園藝學研究所 | zh_TW |
| 顯示於系所單位： | 園藝暨景觀學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-101-1.pdf 目前未授權公開取用 | 1.7 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。